2-(2,6-Difluorophenyl)acetamide

Catalog No.: 
ACRXPQ810
CAS No.: 
1006608-67-8
Molecular Formula: 
C8H7F2NO
Molecular Weight: 
171.15
2-(2,6-Difluorophenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$245.00InquiryInquiry
1g95%$627.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2,6-Difluorophenyl)acetamide
IUPAC Name2-(2,6-difluorophenyl)acetamide
MDL No.-
Molecular FormulaC8H7F2NO
Molecular Weight171.15
SMILESO=C(N)CC1=C(F)C=CC=C1F
InChI KeyDEKLINATNSGZGE-UHFFFAOYSA-N
Synonym2-(2,6-difluorophenyl)acetamide;Benzeneacetamide, 2,6-difluoro-;2,6-Difluorobenzeneacetamide
CAS No.1006608-67-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRXPQ810 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. ACKPFN013 route compound structure diagram
    ACKPFN01385068-28-6In Stock
  4. Then
  5. ACRXPQ810 route product structure diagram
    ACRXPQ8101006608-67-8
Inquiry

2. ACRXPQ810 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. ACFUNX261 route compound structure diagram
    ACFUNX261116622-90-3In Stock
  4. Then
  5. ACRXPQ810 route product structure diagram
    ACRXPQ8101006608-67-8
Inquiry

3. ACRXPQ810 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHUJC695 route compound structure diagram
    ACHUJC695872046-08-7In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACRXPQ810 route product structure diagram
    ACRXPQ8101006608-67-8
Inquiry

Comments (0)